MYGN Competitors & Alternatives
Compare Myriad Genetics Inc with similar stocks in the same industry
Diagnostics & Research
MYGN
Main Stock$5.68
Tradestie Score
38
Market Cap
$719.23M
Revenue Growth
0.0%
Analyst Upside
-8.1%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc. Common Stock
|
$121.35
|
$2.24B | - | 55 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$29.48
|
$2.22B | - | 40 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$114.22
|
$1.77B | - | 53 | Compare |
|
NEOG
Neogen Corp
|
$11.19
|
$1.26B | - | 44 | Compare |
|
OPK
Opko Health Inc.
|
$1.67
|
$1.23B | - | 44 | Compare |
|
NEO
NeoGenomics, Inc.
|
$16.54
|
$1.13B | - | 44 | Compare |
|
CDNA
CareDx, Inc.
|
$79.81
|
$798.40M | 34.2 | 30 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$24.85
|
$719.31M | - | 32 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$34.50
|
$667.77M | - | 41 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$15.86
|
$612.76M | - | 50 | Compare |
More MYGN Analysis
Data updated: Nov 13, 2026 | Industry: Diagnostics & Research (SIC 2835)
39 stocks in this industry